EATON: An open-label, multicenter, phase I dose-escalation trial of nazartinib (EGF816) and trametinib in patients with EGFR-mutant non-small cell lung cancer - preliminary data on safety and tolerability

Authors :: Michels, S
Nogova, L
Deschler-Baier, B
Sebastian, M
Schuler, M
Wermke, M
Felip, E
Rodriguez-Abreu, D
Rosell, R
Abdulla, DSY
Fischer, RN
Koleczko, S
Kron, A
Pinto, A
Riedel, R
Scheffler, M
Suptitz, J
Fassunke, J
Merkelbach-Bruse, S
Hellmich, M
Buttner, R
Wolf, J
Source :: Oncology Research and Treatment, r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol, instname
Publication Year :: 2019
Publisher :: S. Karger AG, 2019.

ISSN :: 22965262
Database :: OpenAIRE
Journal :: Oncology Research and Treatment, r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol, instname
Accession number :: edsair.RECOLECTA.....be0f3e41924e65d9109c2dabd6ab782d

Tools